Encompass Health Corporation (EHC) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 873.40M USD | Liabilities, Current |
| Cash and equivalents | 107.70M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $873.40M | $107.70M | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $876.80M | $110.50M | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $836.40M | $72.20M | (m) | $613.40M | (m) | (m) |
| 2025-09-30 | (m) | $762.00M | $48.70M | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $865.10M | $99.10M | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $856.00M | $95.80M | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $841.00M | $85.40M | (m) | $593.00M | (m) | (m) |
| 2024-09-30 | (m) | $897.40M | $147.80M | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $694.50M | $154.40M | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $680.30M | $134.40M | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $656.40M | $69.10M | (m) | $599.80M | (m) | (m) |
| 2023-09-30 | (m) | $639.20M | $99.70M | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $655.00M | $117.50M | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $592.10M | $85.00M | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $575.90M | $21.80M | (m) | $524.80M | (m) | (m) |
| 2022-09-30 | (m) | $604.70M | $59.80M | (m) | $500.10M | (m) | (m) |
| 2022-06-30 | (m) | $835.40M | $186.50M | (m) | $658.70M | (m) | (m) |
| 2022-03-31 | (m) | $754.50M | $94.20M | (m) | $683.50M | (m) | (m) |
| 2021-12-31 | (m) | $748.80M | $54.80M | (m) | $666.60M | (m) | (m) |
| 2021-09-30 | (m) | $793.90M | $94.80M | (m) | $637.80M | (m) | (m) |
| 2021-06-30 | (m) | $804.50M | $73.20M | (m) | $627.50M | (m) | (m) |
| 2021-03-31 | (m) | $812.20M | $223.90M | (m) | $633.60M | (m) | (m) |
| 2020-12-31 | (m) | $717.30M | $224.00M | (m) | $563.00M | (m) | (m) |
| 2020-09-30 | (m) | $682.50M | $450.00M | (m) | $593.30M | (m) | (m) |
| 2020-06-30 | (m) | $664.40M | $419.00M | (m) | $553.20M | (m) | (m) |
| 2020-03-31 | (m) | $586.20M | $104.90M | (m) | $543.40M | (m) | (m) |
| 2019-12-31 | (m) | $721.00M | $94.80M | (m) | $498.70M | (m) | (m) |
| 2019-09-30 | (m) | $1.11B | $422.00M | (m) | $516.90M | (m) | (m) |
| 2019-06-30 | (m) | $752.90M | $221.70M | (m) | $496.00M | (m) | (m) |
| 2019-03-31 | (m) | $768.20M | $56.10M | (m) | $500.60M | (m) | (m) |
| 2018-12-31 | (m) | $672.50M | $69.20M | (m) | $459.90M | (m) | (m) |
| 2018-09-30 | (m) | $609.60M | $56.90M | (m) | $458.00M | (m) | (m) |
| 2018-06-30 | (m) | $573.90M | $59.00M | (m) | $456.60M | (m) | (m) |
| 2018-03-31 | (m) | $572.00M | $86.40M | (m) | $463.10M | (m) | (m) |
| 2017-12-31 | (m) | $517.50M | $54.40M | (m) | $459.50M | (m) | (m) |
| 2017-09-30 | (m) | $511.20M | $67.60M | (m) | $441.60M | (m) | (m) |
| 2017-06-30 | (m) | $493.30M | $71.10M | (m) | $426.50M | (m) | (m) |
| 2017-03-31 | (m) | $487.30M | $61.20M | (m) | $438.00M | (m) | (m) |
| 2016-12-31 | (m) | $475.60M | $40.50M | (m) | $432.00M | (m) | (m) |
| 2016-09-30 | (m) | $476.00M | $76.40M | (m) | $419.20M | (m) | (m) |
| 2016-06-30 | (m) | $459.10M | $70.30M | (m) | $420.60M | (m) | (m) |
| 2016-03-31 | (m) | $463.80M | $73.20M | (m) | $431.90M | (m) | (m) |
| 2015-12-31 | (m) | $426.40M | $61.60M | (m) | $410.50M | (m) | (m) |
| 2015-09-30 | (m) | $403.60M | $801.60M | (m) | $350.90M | (m) | (m) |
| 2015-06-30 | (m) | $364.60M | $45.50M | (m) | $351.80M | (m) | (m) |
| 2015-03-31 | (m) | $497.60M | $208.30M | (m) | $337.90M | (m) | (m) |
| 2014-12-31 | (m) | $364.30M | $66.70M | (m) | $323.20M | (m) | (m) |
| 2014-09-30 | (m) | $514.70M | $272.30M | (m) | $261.60M | (m) | (m) |
| 2014-06-30 | (m) | $299.30M | $65.80M | (m) | $272.30M | (m) | (m) |
| 2014-03-31 | (m) | $302.00M | $53.10M | (m) | $272.70M | (m) | (m) |
| 2013-12-31 | (m) | $311.60M | $64.50M | (m) | $261.80M | (m) | (m) |
| 2013-09-30 | (m) | $311.80M | $65.00M | (m) | $253.40M | (m) | (m) |
| 2013-06-30 | (m) | $311.60M | $68.70M | (m) | $273.70M | (m) | (m) |
| 2013-03-31 | (m) | $317.00M | $80.10M | (m) | $266.30M | (m) | (m) |
| 2012-12-31 | (m) | $300.90M | $132.80M | (m) | $249.30M | (m) | (m) |
| 2012-09-30 | (m) | $377.80M | $163.20M | (m) | $247.50M | (m) | (m) |
| 2012-06-30 | (m) | $324.60M | $41.10M | (m) | $245.70M | (m) | (m) |
| 2012-03-31 | (m) | $314.70M | $44.30M | (m) | $244.00M | (m) | (m) |
| 2011-12-31 | (m) | $313.20M | $30.10M | (m) | $222.80M | (m) | (m) |
| 2011-09-30 | (m) | $288.10M | $47.70M | (m) | $219.20M | (m) | (m) |
| 2011-06-30 | (m) | $319.10M | $60.30M | (m) | $212.80M | (m) | (m) |
| 2011-03-31 | (m) | $337.90M | (m) | (m) | $240.90M | (m) | (m) |
| 2010-12-31 | (m) | $359.30M | (m) | (m) | $224.90M | (m) | (m) |
| 2010-09-30 | (m) | $390.00M | (m) | (m) | $215.20M | (m) | (m) |
| 2010-06-30 | (m) | $391.40M | (m) | (m) | $224.80M | (m) | (m) |
| 2009-12-31 | (m) | $391.20M | (m) | (m) | $219.70M | (m) | (m) |
| 2008-12-31 | (m) | (m) | $31.70M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |